Name: UMIN ID:
Unique ID issued by UMIN | UMIN000052422 |
---|---|
Receipt number | R000058807 |
Scientific Title | Evaluation of Intervention Effectiveness Using VR Materials to Reduce Discriminatory Attitudes of College Students Toward Persons with Autism Spectrum Disorders (ASD). |
Date of disclosure of the study information | 2023/10/05 |
Last modified on | 2024/01/31 21:43:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2023/10/05 14:52:54 | ||
2 | Update | 2023/10/05 14:54:45 | Primary outcomes Key secondary outcomes |
|
3 | Update | 2023/10/05 15:35:13 | 1st name of lead principal investigator Last name of lead principal investigator |
|
4 | Update | 2023/10/05 15:37:51 | Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2023/10/05 16:01:51 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
6 | Update | 2023/10/05 16:47:29 | Basic design Purpose of intervention Interventions/Control_1 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2023/10/05 17:08:35 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2023/10/05 17:10:59 | Interventions/Control_2 |
|
9 | Update | 2023/10/06 10:26:50 | Classification by specialty Narrative objectives1 Narrative objectives1 Trial characteristics_1 |
|
10 | Update | 2023/10/06 10:46:54 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
11 | Update | 2023/10/06 10:55:37 | Zip code TEL Organization1 Organization Organization |
|
12 | Update | 2023/10/06 10:58:01 | Last follow-up date |
|
13 | Update | 2023/10/15 10:02:30 | Interventions/Control_1 Interventions/Control_1 |
|
14 | Update | 2023/11/07 16:31:25 | Recruitment status Last follow-up date Date trial data considered complete |
|
15 | Update | 2024/01/31 17:56:03 | Recruitment status Date of closure to data entry |
|
16 | Update | 2024/01/31 21:43:42 | Number of participants that the trial has enrolled |